Company F-star Therapeutics, Inc.
Equities
FSTX
US30315R1077
Biotechnology & Medical Research
Business Summary
Number of employees: 84
Managers
Managers | Title | Age | Since |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20-11-19 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Trish Hurley
LAW | General Counsel | - | - |
James Sandy
PRN | Corporate Officer/Principal | - | 22-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20-11-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,981,919 | 21,095,716 ( 95.97 %) | 0 | 95.97 % |
Company contact information
F-star Therapeutics, Inc.
Eddeva B920 Babraham Research Campus
CB22 3AT, Cambridge
+
http://www.f-star.comSector
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |